Praxis Precision Medicine...

36.96
0.96 (2.67%)
At close: Apr 28, 2025, 10:26 AM

Praxis Precision Medicines Statistics

Share Statistics

Praxis Precision Medicines has 20.16M shares outstanding. The number of shares has increased by 17.86% in one year.

Shares Outstanding 20.16M
Shares Change (YoY) 17.86%
Shares Change (QoQ) 8.18%
Owned by Institutions (%) 99.99%
Shares Floating 18.74M
Failed to Deliver (FTD) Shares 171
FTD / Avg. Volume 0.03%

Short Selling Information

The latest short interest is 1.99M, so 10.66% of the outstanding shares have been sold short.

Short Interest 1.99M
Short % of Shares Out 10.66%
Short % of Float 10.68%
Short Ratio (days to cover) 4.37

Valuation Ratios

The PE ratio is -7.54 and the forward PE ratio is -3.02. Praxis Precision Medicines's PEG ratio is 0.17.

PE Ratio -7.54
Forward PE -3.02
PS Ratio 161.13
Forward PS 1.9
PB Ratio 3.09
P/FCF Ratio -10.46
PEG Ratio 0.17
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Praxis Precision Medicines.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.77, with a Debt / Equity ratio of 0.

Current Ratio 10.77
Quick Ratio 10.77
Debt / Equity 0
Debt / EBITDA -0.01
Debt / FCF -0.01
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $73.73K
Profits Per Employee $-1.58M
Employee Count 116
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -34.32% in the last 52 weeks. The beta is 2.68, so Praxis Precision Medicines's price volatility has been higher than the market average.

Beta 2.68
52-Week Price Change -34.32%
50-Day Moving Average 43.52
200-Day Moving Average 60.89
Relative Strength Index (RSI) 48.79
Average Volume (20 Days) 542.09K

Income Statement

In the last 12 months, Praxis Precision Medicines had revenue of 8.55M and earned -182.82M in profits. Earnings per share was -10.21.

Revenue 8.55M
Gross Profit 8.55M
Operating Income -200.16M
Net Income -182.82M
EBITDA -200.16M
EBIT -200.16M
Earnings Per Share (EPS) -10.21
Full Income Statement

Balance Sheet

The company has 215.37M in cash and 1.37M in debt, giving a net cash position of 214M.

Cash & Cash Equivalents 215.37M
Total Debt 1.37M
Net Cash 214M
Retained Earnings -836.74M
Total Assets 483.11M
Working Capital 366.82M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -131.76M and capital expenditures 0, giving a free cash flow of -131.76M.

Operating Cash Flow -131.76M
Capital Expenditures 0
Free Cash Flow -131.76M
FCF Per Share -7.36
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -2340.29% and -2137.48%.

Gross Margin 100%
Operating Margin -2340.29%
Pretax Margin -2137.48%
Profit Margin -2137.48%
EBITDA Margin -2340.29%
EBIT Margin -2340.29%
FCF Margin -1540.48%

Dividends & Yields

PRAX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for PRAX is $105, which is 191.7% higher than the current price. The consensus rating is "Buy".

Price Target $105
Price Target Difference 191.7%
Analyst Consensus Buy
Analyst Count 9
Stock Forecasts

Stock Splits

The last stock split was on Nov 29, 2023. It was a backward split with a ratio of 1:15.

Last Split Date Nov 29, 2023
Split Type backward
Split Ratio 1:15

Scores

Altman Z-Score 8.43
Piotroski F-Score 4

Advertisement